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The lipase inhibitors, Triton WR-1339 and tetrahydrolipstatin, were incubated with rat hepatocytes. Triton WR-1339 increased the recovery of 
triacylglycerol in the hepatocytes and incubation medium by 31% and 38%, respectively. Tetrahydrolipstatin decreased the accumulation of newly 
synthesized, and of total triacylglycerol inthe medium. This compound might be useful in determining mechanisms involved in intracellular triacyl- 
glycerol metabolism and the secretion of very low density lipoproteins. 
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1 s INTRODUCTION 
There is great interest in studying the mechanisms 
that control the secretion of very low density lipopro- 
teins (VLDL) and much of this work is now being done 
with monolayer cultures of hepatocytes. One potential 
problem with this kind of experiment is that there may 
be degradation of secreted triacylglycerol during an ex- 
tended culture period. This could be caused by ex- 
tracellular lipolysis due to the secretion of hepatic lipase 
[l-3]. We therefore undertook experiments to deter- 
mine the effect of inhibiting extracellular lipase activity 
on the accumulation of triacylglycerols in the medium 
of cultured rat hepatocytes. 
For this study we chose to use the compound, 
tetrahydrolipstatin, which is a derivative of microbial 
lipstatin and which is a specific inhibitor of acylgly- 
cerolipases, but not Ca”’ -dependent phospholipases 
P-61. Tetrahydrolipstatin forms a covalent bond with 
the active site serine of the lipases [7]. This inhibitor has 
been used to inhibit the digestion and absorption of 
triacylglycerol from the small intestine because of its ac- 
tion in decreasing astric lipase, carboxylester lipase 
and pancreatic lipase activities [4-71. It therefore ap- 
peared to be an ideal inhibitor to add to the culture 
medium of the hepatocytes in order to prevent ex- 
tracellular degradation of triacylglycerol. We tested 
whether this compound would ;nc:ease the recovery of 
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triacylglycerol in VLDL from cultures of rat 
hepatocytes. As a comparison, we used the well known 
non-specific lipase inhibitor, Triton WR 1339 [8]. 
2. MATERIALS AND METHODS 
2.1. Animals and materials 
The sources of most of the materials have been described previously 
[9-l I]. Radiochemicals were purchased from Amersham Interna- 
tional and Triton WR-1339 (Tyloxapol) was from Sigma Chemical 
Co., St. Louis, MO, USA. Tetrahydrolipstatin was a gift from Dr 
M.K. Meier, Hoffman-La Troche Ltd, Basel, Switzerland. It was 
dissolved in dimethyl sulfoxide at a concentration of 240 mM for use 
in the assays. Male Wistar rats weighing about 200 g were supplied by 
Charles River, QuCbec, Canada. 
2.2. Preparalion and incubation of kepatocytes 
Hepatocytes were prepared as described previously and approx- 
imately 2 x 10”celIs were applied to tissue culture dishes that had been 
previously coated with collagen. The cells were incubated for 1 h in 
modified Leibovitz L-15 medium (g-111 containing 10% (v/v) 
newborn calf serum in air at 9G% humidity. Unattached and non- 
viable cells were removed by changing the medium and the cells were 
incubated for a further 3 h. The medium was changed, but this time 
it contained 0.03 mM fatty acid poor bovine serum albumin instead 
of 10% serum, and the incubation was continued overnight. The cells 
were then incubated for a further 1 h in a similar medium in which the 
albumin concentration was increased to 0.1 mM. The cells were then 
incubated in fresh medium containing the additions as indicated, At 
the completion of the incubation, the supernatant was collected from 
triplicate dishes, centrifuged at 10000 rpm for 10 min at 4OC to 
remove detached cells and cell debris. The monolayers of hepatocytes 
were washed with 2 x 2.5 ml of 0.15 NaCl and then scraped from the 
dishes in I ml of ice-cold 0.25 mM sucrose containing 0,s mM 
dithiothreitol und 10 mM HEPES (pH 7.4). The cell suspensions 
from triplicate dishes were pooled, sonicatcd and the viability of the 
cells was determined by measuring lactate dehydrogcnase uctivity 
[IO, I1 1. Damage and permeabilization of the cells results in the loss 
of this enzyme, We were therefore able to ensure that this did not hap- 
pelt in the incubations reported in this paper, The results have been 
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expressed relative to the activity of lactate dehydrogenase in the cells 
to compensate for small differences in the number of hepatocytes per 
dish. This method is considered superior to the measurement of DNA 
or protein since non-viable cells which may be still attached to the 
dishes could contribute to these latter values and the incubations con- 
tain relatively high albumin concentrations [lO,ll]. One dish of cells 
contained about I .5 mg of hepatocyte protein. 
2.3. Measurement of triecylglyserol 
The mass of triacylglycero! in the cells and medium was determined 
[I21 after extracting lipid by the method of Bligh and Dyer [13]. A 
standard of triolein was used and tk&e concentration of triacylglycero! 
was determined with a ‘triglyceride GPOP-PAP’ test combination 
reagent purchased from Boehringer Mannheim, Germany. Twenty PI 
of propan-Z-o! were added to each tube in order to solubilize the lipid 
before adding 350~1 of the color reagent. Triacylglycero! in the 
medium could not be assayed directly after extraction because of 
subsequent urbidity caused by fatty acid 1141. In this case, the whole 
bottom phase (about 2.5 ml) was shaken with I g of basic alumina to 
remove residual oleate [14]. After centrifuging for 30 min and 
10000 x g. 1.6 ml of supernatant was taken and the solvent was 
removed before determining triacylglycero! concentrations. The addi- 
tion of dimethy! sulfoxide, tetrahydrolipstatin and Triton WR-1339 
to the medium did not interfere with this analysis. 
In other experiments, the incorporation of [I ,3-3H]g!yceroI into 
lipids was used to determine the accumulation of newly synthesized 
triacylglycero! in the hepatocytes and secretion into the medium. 
Lipids were then extracted from the cells and medium as described 
above. Triacylglycero! was separated from other lipids by thin layer 
chromatography on silica gel 60 (from Merck, Darmstadt, Germany). 
Plates were developed with light petroleum bp. 40-60VYdiethyl 
ether/acetic acid (50:50: I, v/v). The radioactivity in the area con- 
taining triacylglycero! was determined after adding 0.5 ml of water 
and 5 ml of Amersham ACS. This method was devised to give good 
recoveries of lipids from silica gel. The water inactivates the silica and 
the lipids dissolve in the detergent and solvent [lS]. 
3. RESULTS AND DISCUSSION 
After incubation for 4 h with Triton WR-1339, the 
amount of triacylglycerol in cells and medium was in- 
creased by 31% and 38% (Table I), respectively, when 
compared to controls. The increase in the recovery in 
the medium is compatible with an inhibition of ex- 
tracellular lipase activity. However, the increase in the 
accumulation of triacylglycerol within the cells in- 
dicates an additional interference with intracellular 
metabolism. Thus although Triton WR-1339 might pro- 
duce the desired effect of inhibiting extracellukr fipases 
[8], its effect on intracellular triacylglycerol raises 
serious doubts about its selectivity. 
We therefore hoped that tetrahydrolipstatin would be 
a much more specific inhibitor. However, this com- 
pound at 200 yM decreased the accumulation of 
triacylglycerol in the medium by about 80% (Table I). 
The recovery of triacylglycerol in the cells was not 
significantiy altered. 
In the second series of experiments we determined the 
effects of tetrahydrolipstatin on newly synthesized 
triacylglycerol by using (‘H]glycerol as a substrate 
(Fig. l), Triacylglycerol radioactivity in the medium 
was progressively decreased as the concentration of 
tctrahydrolipstatin increased, thus confirming the 
Table I 
Relative effect of Triton WR-1339 and tetrahydrolipstatin on the 
accumulation and secretion of triacylglycero! by rat hepatocytes 
Relative amounts (070) 
Triton WR-1339 
to.1 To) 
Tetrahydrolipstatin 
I200 &Ml 
Cells 131 * 2.4** 90 * 8.8 
Medium 138 -t 4.4’ 20 I 3.9* 
Cells + medium 132 + 1.3** 79 * 7.5 
Results are expressed relative to incubations that contained no 
inhibitor and the values are means f SE of 4 independent 
experiments, for Triton WR-1339 and three independent experiments 
for tctrahydrolipstatin. Absolute amounts of triacylglycero! in 
control incubations after 4 h were 151 + 7.6 and 25 -c 1.8 nmo!/unit 
of cellular LDH for the cells and medium, respectiveIy. The 
significance of the difference relative to the control was calculated by 
a paired t-test and it is indicated by: * P < 0.005 and ** P e 0.001 
results in Table I. At the same time, the accumulation 
of triacylglycerol radioactivity in the cells increased up 
to a concentration of 500 PM tetrahydrolipstatin. This 
increase was not reflected in the triacylglycerol mass 
(Table I). However, the triacyIgIycero1 that is synthesiz- 
ed from [3H]glycerol in presence of 200&4 
tetrahydrolipstatin (Fig. 1) accounted for only about 
19% of the triacylglycerol in the cells and about 11% of 
that in the medium compared with the total 
triacylglycerol mass. This calculation is based upon the 
specific radioactivity of the [3H]glycerol and there 
would have been changes in the specific activity of the 
precursor pool of [3H]glycero1-3-phosphate. 
I 
'OU 200 400 800 BOO 1000 
[Tetrahydrollpetetln] (PM) 
Fig. 1, Effect of tetrahydrolipstatin on the accumulation and 
secretion of newly-synthesized triacylglyccro! in rat hepatocytes. 
Hepatocytes were incubated for 8 h with 0.1 mM fatty acid poor 
bovine serum albumin, I mM [~HJglycero! (9 CVmol), ICOkM 
choline and tetrahydralipstatin RS indicated. The results are means 
from two independent experiments. The absolute values for the 
incorporation of [3HJglycero! into triocylglycerol in the absence of 
tetrahydrolipstatin were 18.0 and I,2 nmo!/uait of cellular lactate 
dchydrogenase for thr cells (0) and medium (a), respectively. 
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It is therefore concluded that tetrahydrolipstatin 
could not be used to enhance the accumulation of 
secreted VLDL triacylglvcerol in the incubation 
medium. In fact, it had an opposite ffect of  decreasing 
the amount of VLDL triacylglycerol. The reason for 
this is not certain at this stage. Tetrahydrolipstatin is 
absorbed from the intestine and it appears in urine and 
bile [6]. It is therefore possible that it could enter the 
hepatoeytes and interfere with VLDL secretion by in- 
hibiting the mobilization of the intracellular 
triacylglycerol pool via lipolysis. This is likely to be a 
prerequisite for subsequent secretion of this 
triacylglycerol that is temporarily stored in the 
hepatocytes [16-181. Such an effect is compatible with 
the accumulation of newly synthesized triacylglycerol 
that was labelled from [3H]glycerol and a decrease in its 
appearance in the medium. The failure of 
tetrahydrolipstatin to increase the mass of 
triacyiglycerol in the hepatocytes i  partly explained by 
the fact that only about 17070 of the total triacylglycerol 
is secreted uring the course of the experiment (Table 
I). Alternatively, tetrahydrolipstatin might block the 
assembly or secretion of VLDL by an action unrelated 
to the effect on lipolysis. 
It is not yet established whether tetrahydrolipstatin 
can inhibit intracellular lipase activities therapeutically 
and decrease VLDL secretion in addition to its effects in 
decreasing fat absorption. Further investigations of the 
mode of action of tetrahydrolipstatin in hepatocytes 
might provide valuable information about intracellular 
triacylglycerol metabolism and VLDL secretion. 
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